X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
hematology (53) 53
index medicus (45) 45
male (44) 44
middle aged (44) 44
female (41) 41
adult (40) 40
aged (38) 38
transplantation (38) 38
oncology (25) 25
stem cells (24) 24
hematology, oncology and palliative medicine (23) 23
immunology (23) 23
chemotherapy (18) 18
treatment outcome (18) 18
hematopoietic stem cells (15) 15
adolescent (14) 14
article (14) 14
transplantation, homologous (14) 14
young adult (14) 14
cancer (11) 11
hematopoietic stem cell transplantation (11) 11
transplantation conditioning - methods (11) 11
transplantation, autologous (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
bone-marrow-transplantation (9) 9
retrospective studies (9) 9
risk factors (9) 9
survival analysis (9) 9
therapy (9) 9
health aspects (8) 8
stem cell transplantation (8) 8
transplantation conditioning (8) 8
acute myeloid-leukemia (7) 7
graft survival (7) 7
graft vs host disease - etiology (7) 7
hematologic neoplasms - therapy (7) 7
hematopoietic stem cell transplantation - methods (7) 7
mortality (7) 7
recurrence (7) 7
unrelated donors (7) 7
aged, 80 and over (6) 6
autologous stem cell transplantation (6) 6
blood (6) 6
bone-marrow (6) 6
care and treatment (6) 6
clinical trials (6) 6
combined modality therapy (6) 6
disease-free survival (6) 6
graft vs host disease - prevention & control (6) 6
hematopoietic stem cell transplantation - adverse effects (6) 6
incidence (6) 6
lymphoma (6) 6
medical research (6) 6
transplantation conditioning - mortality (6) 6
trial (6) 6
colony-stimulating factor (5) 5
cord blood stem cell transplantation - adverse effects (5) 5
engraftment (5) 5
epidemiology (5) 5
follow-up studies (5) 5
g-csf (5) 5
hematologic neoplasms - complications (5) 5
histocompatibility testing (5) 5
kaplan-meier estimate (5) 5
leukemia (5) 5
medicine, experimental (5) 5
multiple myeloma (5) 5
prognosis (5) 5
remission induction (5) 5
stem-cell transplantation (5) 5
survival rate (5) 5
versus-host-disease (5) 5
vidarabine - analogs & derivatives (5) 5
analysis (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
antineoplastic agents - adverse effects (4) 4
autologous transplantation (4) 4
blood transplantation (4) 4
busulfan (4) 4
cells (4) 4
comparative analysis (4) 4
dose-response relationship, drug (4) 4
granulocyte colony-stimulating factor - administration & dosage (4) 4
hematologic neoplasms - mortality (4) 4
impact (4) 4
leukemia, myeloid, acute - therapy (4) 4
melphalan - administration & dosage (4) 4
melphalan - therapeutic use (4) 4
multiple myeloma - therapy (4) 4
non-hodgkins-lymphoma (4) 4
progenitor cells (4) 4
relapse (4) 4
risk-factors (4) 4
rituximab (4) 4
time factors (4) 4
virus diseases (4) 4
3rd-party donor (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 6, pp. 930 - 937
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2017, Volume 23, Issue 3, pp. S265 - S265
Journal Article
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, ISSN 1083-8791, 06/2019, Volume 25, Issue 10, pp. 1984 - 1992
Relapse remains the major cause of death in older patients transplanted for acute myeloid leukemia (AML) in first complete remission or for patients with... 
Journal Article
Bone marrow transplantation, ISSN 0268-3369, 06/2019
High-dose melphalan (MEL200) followed by autologous stem cell transplantation (ASCT) remains a standard of care for multiple myeloma (MM). Bendamustine induces... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2018, Volume 24, Issue 3, pp. S209 - S210
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3496 - 3496
Abstract Background: Umbilical cord blood transplantation has been used for hematologic malignancy patients lacking matching donors but slow engraftment has... 
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 09/2014, Volume 12, Issue 9, pp. 565 - 573
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 12/2012, Volume 18, Issue 12, p. 1867
The CXCR4 antagonist plerixafor is increasingly used in the mobilization regimens for autologous peripheral blood stem cell (PBSC) transplantation. This agent... 
Journal Article
Blood, ISSN 0006-4971, 08/2014, Volume 124, Issue 7, pp. 1183 - 1191
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S110 - S111
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2014, Volume 32, Issue 29, pp. 3264 - 3274
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 04/2018, Volume 103, Issue 5, pp. 770 - 777
Gene therapy for sickle cell disease is limited by the yield of hematopoietic progenitor cells that can be harvested for transduction or gene editing. We... 
HEALTHY DONORS | STEM-CELLS | ACTIVATION | COLONY-STIMULATING FACTOR | BONE-MARROW | HYDROXYUREA | RISK | GENE-THERAPY | HEMATOLOGY | G-CSF | BLOOD
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2015, Volume 21, Issue 10, pp. 1808 - 1814
Abstract Few studies have evaluated the role of antibacterial prophylaxis during neutropenia in patients with multiple myeloma undergoing autologous... 
Hematology, Oncology and Palliative Medicine | Autologous stem cell transplantation | Multiple myeloma | Fluoroquinolone prophylaxis | RISK-FACTORS | ANTIBACTERIAL PROPHYLAXIS | IMMUNOLOGY | RECIPIENTS | CANCER | EMERGENCE | CLOSTRIDIUM-DIFFICILE | TRANSPLANTATION | DIFFICILE-ASSOCIATED-DIARRHEA | MORBIDITY | COMPLICATIONS | HEMATOLOGY | EPIDEMIOLOGY | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Antibiotic Prophylaxis | Clostridium Infections - epidemiology | Clostridium difficile - isolation & purification | Melphalan - therapeutic use | Febrile Neutropenia - prevention & control | Incidence | Bacteremia - microbiology | Enterobacteriaceae Infections - epidemiology | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Bacteremia - prevention & control | Lymphoma - therapy | Drug Resistance, Multiple, Bacterial | Levofloxacin - therapeutic use | Female | Filgrastim - therapeutic use | Retrospective Studies | Levofloxacin - administration & dosage | Febrile Neutropenia - epidemiology | Multiple Myeloma - complications | Risk Factors | Enterobacteriaceae Infections - etiology | Hematopoietic Stem Cell Transplantation | Combined Modality Therapy | Drug Resistance, Microbial | Febrile Neutropenia - etiology | Guideline Adherence | Febrile Neutropenia - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Enterobacteriaceae - drug effects | Bacteremia - epidemiology | Immunocompromised Host | Transplantation Conditioning | Antifungal Agents - administration & dosage | Practice Guidelines as Topic | Levofloxacin | Analysis | Stem cells | Transplantation | Health aspects | Hyperthermia | Fever | Hematopoietic stem cells
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.